OPEN MARKET SALE AGREEMENT SMOpen Market Sale Agreement • June 4th, 2021 • Ayala Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Board of Directors or committees, the Company has provided Davis Polk & Wardwell LLP and Latham & Watkins LLP with originals or true, correct and complete copies of draft minutes or written agendas relating thereto, which drafts and agendas, if any, reflect all material events that occurred in connection with such proceedings. There have been no material changes, additions or alterations in said minute books, records and other documents that have not been disclosed to Davis Polk & Wardwell LLP or Latham & Watkins LLP in writing.
